ATLASDecoy Therapeutics (DCOY) earnings date: Nov 13, 2026
Decoy Therapeutics (DCOY) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on DCOY
| Last price | $1.07 (-13.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±7.8% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Decoy Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Decoy Therapeutics reports on Nov 13, 2026. One email the day before, with ATLAS’s read on Decoy Therapeutics. You can switch it off at any time.
Alert me before DCOY reportsFree to start. Creating an account takes under a minute.
Notify me when Decoy Therapeutics reports
Track DCOY free Add Decoy Therapeutics to a free ATLAS watchlist and see its next report date in one place.
DCOY earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 12, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +34.3% |
| Average move around a report | ±8.5% (last 5) |
| Sector | Healthcare · Biotechnology |
Decoy Therapeutics earnings history: last 5 reports
Decoy Therapeutics last reported on Aug 12, 2026: EPS of -$4.46 against an estimate of -$2.88 (-54.9% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$2.88 | -$4.46 | -54.9% | Miss | -8.8% |
| May 8, 2026 | -$4.08 | -$4.18 | -2.5% | Miss | -5.2% |
| Mar 27, 2026 | -$3.78 | -$0.97 | +74.3% | Beat | -3.8% |
| Mar 17, 2026 | $0.42 | $0.65 | +54.8% | Beat | -0.8% |
| Nov 14, 2025 | -$8,481.60 | -$21.72 | +99.7% | Beat | -24.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for DCOY
See the fair value, the probability range and the earnings history of Decoy Therapeutics on its ATLAS page.
Decoy Therapeutics (DCOY) stock analysisPlans from €3.99 a month.
Decoy Therapeutics earnings: frequently asked questions
When does Decoy Therapeutics (DCOY) report earnings?
Decoy Therapeutics is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does DCOY beat earnings estimates?
Of its last 5 reports with a recorded result, Decoy Therapeutics beat the EPS estimate 3 times; the average surprise was +34.3%. Past results do not predict the next one.
How much does DCOY move around earnings?
Over its last 5 reports the stock moved an average of 8.5% (absolute, from the close before the report day to the close after it), and finished higher 0 of 5 times.
Did Decoy Therapeutics beat earnings estimates last quarter?
Decoy Therapeutics last reported on Aug 12, 2026: EPS of -$4.46 against an estimate of -$2.88 (-54.9% surprise), a miss.
How much does DCOY usually move in a day?
On a normal trading day the ATLAS model puts DCOY’s one-day range at about ±7.8%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer